Cancer
Recent articles
Understanding fragile X syndrome
Just in time for Fragile X Awareness Month, The Transmitter rounds up notable coverage.
Understanding fragile X syndrome
Just in time for Fragile X Awareness Month, The Transmitter rounds up notable coverage.
Faked results lead to retraction of high-profile cancer neuroscience study
An investigation found that the experiments required more animals than the scientists had purchased.
Faked results lead to retraction of high-profile cancer neuroscience study
An investigation found that the experiments required more animals than the scientists had purchased.
Going deep: The Transmitter’s top long-form stories in 2023
Our favorite features and book excerpts from the past year delved into the neurobiology of cancer; problems with survey data; free will; mathematical minds; and questions around one startup’s quest to treat brain conditions with cell therapies.
Going deep: The Transmitter’s top long-form stories in 2023
Our favorite features and book excerpts from the past year delved into the neurobiology of cancer; problems with survey data; free will; mathematical minds; and questions around one startup’s quest to treat brain conditions with cell therapies.
Making cancer nervous
Nerve cells in the brain and throughout the body can turbocharge tumor growth — a finding that not only expands conventional ideas about the nervous system but points to novel therapeutic targets for a range of malignancies.
Making cancer nervous
Nerve cells in the brain and throughout the body can turbocharge tumor growth — a finding that not only expands conventional ideas about the nervous system but points to novel therapeutic targets for a range of malignancies.
Mitochondria mediate effects of PTEN mutations
Whole-genome sequencing data — which include information about mitochondrial DNA — offer clues to why mutations in the same gene can lead to autism or cancer.
Mitochondria mediate effects of PTEN mutations
Whole-genome sequencing data — which include information about mitochondrial DNA — offer clues to why mutations in the same gene can lead to autism or cancer.
The cloudy connection between fragile X and cancer
People with the autism-linked syndrome lack a protein implicated in several cancers, but it’s unclear whether — or how — they are protected from malignancies.
The cloudy connection between fragile X and cancer
People with the autism-linked syndrome lack a protein implicated in several cancers, but it’s unclear whether — or how — they are protected from malignancies.
Two groups of neurons govern autism-like traits in model mice
Together, the neurons are part of the corticostriatal circuit, which has been implicated in autism.
Two groups of neurons govern autism-like traits in model mice
Together, the neurons are part of the corticostriatal circuit, which has been implicated in autism.
Proteome map identifies more than 90 percent of all human proteins
Researchers expand on the already enormous progress made on the Human Proteome Project
Proteome map identifies more than 90 percent of all human proteins
Researchers expand on the already enormous progress made on the Human Proteome Project
Scores forecast effects of mutations in autism gene
A new analysis links individual mutations in a gene called PTEN to a person's odds of having autism, cancer or other conditions.
Scores forecast effects of mutations in autism gene
A new analysis links individual mutations in a gene called PTEN to a person's odds of having autism, cancer or other conditions.
Large mutations may explain diverse outcomes from autism gene
Deletions and duplications of long stretches of DNA may increase the likelihood of autism in people who have a mutation in a gene called PTEN.
Large mutations may explain diverse outcomes from autism gene
Deletions and duplications of long stretches of DNA may increase the likelihood of autism in people who have a mutation in a gene called PTEN.
Explore more from The Transmitter
Remembering the life of neuropharmacologist Floyd Bloom
The co-author of the classic textbook “The Biochemical Basis of Neuropharmacology” and pioneer in studying the roles of neurotransmitters in the brain died on 8 January at 88 years old.
Remembering the life of neuropharmacologist Floyd Bloom
The co-author of the classic textbook “The Biochemical Basis of Neuropharmacology” and pioneer in studying the roles of neurotransmitters in the brain died on 8 January at 88 years old.
Newly characterized striatal circuits add twist to ‘go/no-go’ model of movement control
The two novel pathways control dopamine release in opposing ways and may link motivation and mood to action, a new study shows.
Newly characterized striatal circuits add twist to ‘go/no-go’ model of movement control
The two novel pathways control dopamine release in opposing ways and may link motivation and mood to action, a new study shows.
Protein aggregates gum up ‘master regulator’ of autism-linked genes
The regulator, CPEB4, typically controls protein production for hundreds of autism-linked genes, but an alternative version of it found in autistic people forms irreversible clumps and malfunctions.
Protein aggregates gum up ‘master regulator’ of autism-linked genes
The regulator, CPEB4, typically controls protein production for hundreds of autism-linked genes, but an alternative version of it found in autistic people forms irreversible clumps and malfunctions.